Screening a maternal Xenopus expression library for activities that synergize with low levels of injected b-catenin, we have isolated a clone encoding the C-terminal end of x-bTrCP-2, a highly conserved protein belonging to the F-box/WD40 family of ubiquitin-ligase specificity factors. We show that x-bTrCP-2 expression reduces dorsal axis formation in Xenopus embryos. A dominant negative mutant lacking the F-box triggers the opposite effect, inducing secondary axes and activating the expression of Wnt responsive genes in ectodermal explants. In light of the existence of bTrCP transcripts associated with the vegetal cortex, we propose that bTrCP plays a fundamental role in the establishment of the dorsal determinants during cortical rotation in Xenopus.
Introduction
The establishment of the body axes is a key event occurring during the early development of all organisms. The amphibian Xenopus laevis is a favorite vertebrate system for the study of the cellular and molecular events controlling this process. After fertilization, the cortex of Xenopus eggs rotates around the underlying cytoplasm, resulting in the displacement of maternal factors from the vegetal pole to the future dorsal side of the embryo. This movement establishes a dorsal signaling center opposite to the sperm entry point, leading to the expression of dorsal-specific genes and to the formation of the Spemann organizer at the beginning of gastrulation (Harland and Gerhart, 1997) .
The Wnt signaling pathway plays a fundamental role in this chain of events. Compelling evidence in support of this view is provided by the demonstration that eggs depleted of maternal mRNA encoding b-catenin, a crucial effector of the Wnt pathway, lack a dorsal axis and are unresponsive to ectopic Wnt signals (Heasman et al., 1994) . Accumulation of b-catenin on the future dorsal side of the Xenopus embryo can be detected from the first cell cycle after fertilization (Larabell et al., 1997) , and ectopic expression of b-catenin in the ventral side leads to the formation of a second dorsal axis (Funayama et al., 1995; Guger and Gumbiner, 1995) . When its cytoplasmic concentration exceeds a defined threshold, b-catenin can migrate to the nucleus and bind to the Tcf/LEF family of transcription factors (Behrens et al., 1996; Huber et al., 1996; Molenaar et al., 1996) ; in one model, this complex binds to the promoter of direct target genes, such as Siamois and Xnr-3, and induces their expression (Brannon et al., 1997; McKendry et al., 1997) . Therefore, the readout of Wnt signaling relies on the tight control of the concentration of b-catenin protein in the cytoplasm and the nucleus .
An important factor in the control of b-catenin stability is GSK-3b, a negative regulator of Wnt signaling and a kinase that phosphorylates b-catenin at amino-terminal serines and threonines. Mutation or deletion of this site prevent the ubiquitination and degradation of b-catenin (Aberle et al., 1997; Yost et al., 1996) . The mechanism by which phosphorylated b-catenin is targeted to the proteasome is still unclear. Several regulators of GSK-3b have been described (Yost et al., 1998 and references therein), but it is not known whether the activity of these molecules is regulated during cortical rotation.
In an effort to isolate genes involved in the establishment of the dorsal axis, we have constructed a cDNA expression library from maternal Xenopus RNA. By coinjecting pools of library-derived transcripts with a low amount of b-catenin RNA, we isolated clones that either enhanced or reduced the number of secondary axes induced by b-catenin alone. Here we describe the isolation of Xenopus b-transducin repeat-containing protein-2 (x-bTrCP-2). x-bTrCP-2 is the Xenopus homolog of slimb, a negative regulator of wingless and hedgehog signaling in Drosophila (Jiang and Struhl, 1998) . Loss of function of slimb results in the accumulation of high levels of both Cubitus interruptus (Ci) (a mediator of hedgehog signaling) and Armadillo (the homolog of b-catenin), resulting in a cell-autonomous activation of these pathways (Jiang and Struhl, 1998) . The human homolog (hbTrCP) was recently found to mediate CD4 degradation through the ubiquitin-proteasome pathway by the HIV-1-encoded Vpu protein (Margottin et al., 1998) . We show here that x-bTrCP-2 regulates Wnt signaling and axis formation in Xenopus. Based on the localized expression of bTrCP transcripts in the vegetal cortex of the egg (Hudson et al., 1996) , we propose that x-bTrCP-2, together with GSK-3b, is an essential regulator of b-catenin stability in the process of cortical rotation.
Results

Cloning of genes involved in axis formation by a modifier screen
In order to elucidate the earliest molecular determinants of the generation of a dorsal axis, we performed an expression screen in which pools of RNA from a maternal Xenopus library were injected with b-catenin RNA into the ventral side of 4-cell stage Xenopus embryos. As the dose of bcatenin RNA injected (50 pg) induced secondary dorsal axes in less than 10% of the embryos, the combination of b-catenin and library RNAs allowed us to screen phenotypically for factors that either interfered or synergized with b-catenin. Positively-scoring pools were further screened for the presence of b-catenin (or the close homolog plakoglobin) RNA by RT-PCR. One b-catenin-free pool that reproducibly increased the number of secondary axes to 50-60% of the injected embryos was fractionated by sib selection and reduced to a single cDNA clone (58DP). Injected alone in the absence of b-catenin in the ventral side, 58DP was able to induce a partial secondary axis ( Fig. 1 ), indicating that it has dorsalizing activity. The sequence analysis of 58DP revealed its identity to bTrCP-2, a partial cDNA isolated in a screen for vegetally localized RNAs (Hudson et al., 1996) . bTrCP, a full-length clone highly homologous to bTrCP-2 (97% identity), had been previously isolated from a Xenopus oocyte cDNA library as a suppresser of the cdc15 mutation in yeast (Spevak et al., 1993) . Since highly conserved homologs have been identified in Drosophila (slimb, Jiang and Struhl, 1998) and in humans (h-bTrCP, Margottin et al., 1998) , we name our clone x-bTrCP-2 to avoid confusion. Two important domains can be recognized in all bTrCP homologs ( Fig.  2) : an F-box motif (residues 113-158), which has been shown to bind SKP1 and thus target proteins to the ubiquitin-mediated proteolytic pathway (Bai et al., 1996 ; reviewed in Patton et al., 1998) ; and seven b-transducin-like (or WD40) repeats (residues 218-510), that act as protein-protein interaction domains (Neer et al., 1994) .
bTrCP reduces primary axis formation
Since the 58DP clone was not complete, we isolated its 5′ region by PCR. The function of the reconstituted full-length x-bTrCP-2 was then assayed by RNA injection in four-cell stage embryos. Surprisingly, delivery of x-bTrCP-2 RNA (1 ng) to the dorsal side strongly reduced axis elongation, while ventral overexpression produced a normal phenotype (Fig. 3 ). This result indicates that full-length x-bTrCP-2 inhibits dorsal development, displaying an effect opposite to that of the partial 58DP clone. Based on its lack of the Fbox and of the first and beginning of the second WD40 repeats (see Fig. 2 ), we postulated that the 58DP clone acted as a weak dominant negative mutant, inhibiting the anti-dorsalizing effects of endogenous bTrCP.
The C-terminal domain of bTrCP induces secondary axes and activates Wnt-responsive genes
To obtain a more effective transdominant mutant and directly test the role of bTrCP in vivo, we generated two truncated constructs: DC226 (aa 1-226, comprising the Fbox) and DN209 (aa 209-518, including the seven WD40 repeats) (Fig. 2) . Injection of DC226 RNA did not produce a phenotype in embryos (data not shown). On the contrary, DN209 expression in the ventral side produced nearly complete secondary axes with high frequency (81%; n = 48) (Fig. 4) . Injection in the dorsal side produced only a slightly thickened notochord (Fig. 4) . We conclude that the deletion of the F-box produces a dominant negative form of bTrCP, especially when all seven WD40 repeats are present (unlike in 58DP). The secondary axis phenotype produced by Fig. 2 . Scheme of the F-box and WD40-repeat domains contained in full-length bTrCP (top), in the library clone 58DP (lacking 269 aa. at the N-terminus) and in the mutants DC226 and DN209. Fig. 3 . x-bTrCP-2 inhibits dorsal axis formation. 5 ng of full-length xbTrCP-2 RNA were injected either in the ventral or the dorsal side of fourcell stage Xenopus embryos. Tadpoles injected dorsally display a severely reduced axis. Ventral injection did not phenotypically affect development. Injection of less than 5 ng of RNA resulted in less severe phenotypes; the requirement of a high dose of full-length x-bTrCP-2 RNA is presumably due to the low amount of protein expressed from this construct (data not shown). DN209 was rescued by coinjecton of an eight-fold excess of full-length x-bTrCP-2 (data not shown). These findings suggest that bTrCP is an endogenous inhibitor of dorsalization.
To test whether it can activate directly the Wnt pathway, we injected DN209 RNA into the animal pole of 2-cell stage embryos in parallel with Xwnt8 RNA. Ectodermal explants were then subjected to RT-PCR to assay for the expression of two direct Wnt responsive markers, siamois (Lemaire et al., 1995) and xnr3 (Smith et al., 1995) . DN209 and Xwnt8 behaved identically, inducing both dorsal genes without inducing the pan-mesodermal marker brachyury (Smith et al., 1991) . Therefore, a dominant negative bTrCP can activate the Wnt pathway in ectodermal cells.
On the basis of the proposed mechanism of action of the human and the Drosophila bTrCP homologs, we suggest that x-bTrCP-2 may target phosphorylated bcatenin to the ubiquitination machinery. In conjunction with GSK-3, bTrCP would then be essential to maintain the steady-state level of b-catenin in the cytoplasm below the signaling threshold. A mutant lacking the F-box may still be able to bind b-catenin with the WD40 domain, but fail to interact with the proteasome; therefore, the expression of such a mutant would result in the accumulation of b-catenin (perhaps regardless of its phosphorylation state) and hence in the generation of a Wnt response. We are currently testing these hypotheses in the context of the Xenopus embryo.
Discussion
Through gain-of-function and loss-of-function experiments, we have shown that bTrCP is an inhibitor of Wnt signaling and of dorsal axis formation in early Xenopus embryos. A bTrCP homolog, slimb, performs a similar role in Drosophila (Jiang and Struhl, 1998) . Human bTrCP was recently shown to form a link between the phosphorylated HIV-1-encoded Vpu protein and Skp1p, a subunit of the ubiquitin-ligase complex that target proteins for degradation by the proteasome (Bai et al., 1996; Margottin et al., 1998) . As Vpu interacts with CD4 in the endoplasmic reticulum, it triggers CD4 ubiquitination and destruction via bTrCP (Margottin et al., 1998) . Since bcatenin stability is also regulated by polyubiquitination (Aberle et al., 1997) , it is likely that x-bTrCP-2 or a close isoform acts as a bridge between b-catenin and the ubiquitination machinery.
At least three forms of bTrCP transcripts exist in early embryos (Spevak et al., 1993; Hudson et al., 1996) . Interestingly, the longest mRNA (4.9 kb) (together with an intermediate form (3.5 kb) that might not be polyadenylated (Spevak et al., 1993) ) is predominantly maternal (present from stage VI oocytes to stage 9 blastulae, and nearly absent later on) (Spevak et al., 1993) and is preferentially localized to the vegetal cortex (Hudson et al., 1996) . A shorter transcript (2.5 kb) is present in oocytes and throughout the early developmental stages to at least the tadpole stage (Spevak et al., 1993) and is enriched in the animal pole cytoplasm of stage VI oocytes (Hudson et al., 1996) . Thus, the 4.9 kb and 3.5 kb transcripts recognized by a bTrCP probe are present at the right time and place in which one would expect to find an activity involved in bcatenin regulation during cortical rotation. It is intriguing to speculate that the vegetally localized transcript might lack the exon(s) encoding the F-box and would then act as an endogenous dominant negative inhibitor of full-length bTrCP.
If the 4.9 kb and 3.5 kb transcripts encoded a full-length protein, then a higher concentration of bTrCP near the vegetal cortex might set an elevated threshold to prevent spurious activation of the Wnt pathway in the absence of a signal. Finally, the disappearance of the maternal vegetally-localized bTrCP transcript at mid-blastula stages (Spevak et al., 1993; Hudson et al., 1996) is likely to result in a decrease in the amount of bTrCP protein in the vegetal pole; this effect could contribute, in conjunction with an upstream signal, to the final burst in the amount of nuclear b-catenin observed in the dorso-vegetal side of blastula stage embryos (Schneider et al., 1996) .
The investigation of these hypotheses might not only shed light on the mechanism of axis formation, but also Fig. 5 . Dominant negative x-bTrCP-2 induces Wnt-responsive genes in ectodermal explants. RNAs encoding Xwnt8 (16 pg) and the DN209-xbTrCP-2 mutant (1 ng) were injected in the animal pole of two-cell stage embryos. Ectodermal explants were prepared at blastula stage and processed for RT-PCR when sibling embryos reached the early gastrula stage. Both Xwnt8 and DN209 induce siamois and xnr3, but not the mesodermal marker brachyury. EF-1a is the loading control.
suggest approaches to interfere with the oncogenic potential of b-catenin (Peifer, 1997) .
Experimental procedures
Construction of a maternal cDNA expression library and in vitro transcription
RNA was extracted from one gram of 4-cell stage embryos homogenized with RNAzol B (Tel-Test). Poly(-A)
+ RNA was selected from total RNA using the OLIGO-TEX mRNA midi kit (Qiagen) and reverse-transcribed using a poly-dT oligonucleotide as primer. The cDNA library was constructed in pCS105 (a derivative of pCS2; Baker and Harland, 1996) which allows directional cloning using the Superscript plasmid system (GIBCO-BRL). DH10B cells were transformed with the product of the ligation and plated at a density of 100 colonies per plate. Each plate was harvested by adding 3 ml of LB medium containing 100 mg/ml ampicillin. An aliquot of 0.5 ml of the bacterial suspension was frozen upon addition of glycerol to 30%, while Plasmid DNA was prepared from the residual 2.5 ml culture with the QIAprep Spin miniprep kit (Qiagen). Pooled or single plasmid DNA was linearized with AscI and used to produce capped synthetic mRNA with SP6 RNA polymerase and the Ambion Message Machine kit.
Xenopus embryos and expression screening
Xenopus laevis embryos obtained by in vitro fertilization were dejellied with 3.5% cysteine, transferred in 3.5% Ficoll and microinjected with the indicated amount of RNA. For the expression screen, 5 ng of pooled library RNA was typically coinjected with 50 pg b-catenin RNA in the ventral side of four-cell stage embryos. Induction of secondary dorsal axes was scored by phenotypic observation at the neurula and tadpole stages. Positive RNA pools were screened by RT-PCR for the absence of b-catenin or plakoglobin RNA; the corresponding bacteria stock of 100 clones was then fractionated in 20 pools of ten clones each, and finally assayed individually. The animal cap assay was performed as previously described (Lagna et al., 1996) .
Cloning of x-bTrCP-2
The 58DP clone contained an insert of approximately 1.8 kb, of which 0.8 kb were in the 3′ untranslated region, with a sequence identical to the partial bTrCP-2 clone previously reported (Hudson et al., 1996) . The coding region displayed also high homology to the isoform bTrCP (Spevak et al., 1993) (XELSBTRCP, GenBank accession number: M98268) and started from a position corresponding to nucleotide 655 of XELSBTRCP. The 5′ end of bTrCP was amplified by RT-PCR with primers based on the XELSBTRCP sequence.
